Paradigm Therapeutics, Inc.
PrivateLast Round
VC Round
Jun 18, 2025
Company Overview
Paradigm Therapeutics, Inc. is a biopharmaceutical company that develops innovative topical therapies for the treatment of rare diseases, specifically Epidermolysis Bullosa.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradigm Therapeutics, Inc. Comparables
Compare Paradigm Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CSA Biotechnologies | 56% | |
| Mariposa Therapeutics | 43% | |
| Aegle Therapeutics Corp | 38% |
Paradigm Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2025 | ||||
| VC Round | May 6, 2025 |
Paradigm Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eshelman Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2025
$13M round led by Eshelman Ventures.
- May 6, 2025
$13M round led by Eshelman Ventures
Paradigm Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Paradigm Therapeutics, Inc.'s valuation, stock price, and market status.
Is Paradigm Therapeutics, Inc. a public or private company?
Paradigm Therapeutics, Inc. is a private company.
What is the current stock price of Paradigm Therapeutics, Inc.?
Paradigm Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Paradigm Therapeutics, Inc. worth (valuation)?
Valuation information for Paradigm Therapeutics, Inc. is not publicly available.
Can I buy Paradigm Therapeutics, Inc. stock?
Paradigm Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Paradigm Therapeutics, Inc.'s last funding round?
Paradigm Therapeutics, Inc.'s most recent funding round was Series B Extension on June 18, 2025.
Who are the main investors in Paradigm Therapeutics, Inc.?
Key investors in Paradigm Therapeutics, Inc. include Eshelman Ventures.
Will Paradigm Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Paradigm Therapeutics, Inc..
How can I track Paradigm Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paradigm Therapeutics, Inc.'s secondary market activity and sign up for updates.